Kola I, Landis J: Can the pharmaceutical industry reduce attrition rates?. Nat Rev Drug Discov. 2004, 3 (8): 711-715. 10.1038/nrd1470.
Article
CAS
PubMed
Google Scholar
Greenberg JD, Bingham CO, Abramson SB, Reed G, Kishimoto M, Hinkle K, Kremer J: Assessment of coxib utilization by rheumatologists for nonsteroidal antiinflammatory drug gastroprotection prior to the coxib market withdrawals. Arthritis Care Res. 2004, 55 (4): 543-550.
Article
Google Scholar
Glessner MR, Heller DA: Changes in related drug class utilization after market withdrawal of cisapride. Am J Manag Care. 2002, 8 (3): 243-250.
PubMed
Google Scholar
National Research Council (U.S.): Toxicity testing in the 21st century a vision and a strategy. 2007, National Academies Press, Washington, DC, [http://site.ebrary.com/id/10197076.]
Google Scholar
Drug Discovery Today.com. [http://www.drugdiscoverytoday.com/view/22374/horizon-2020-a-new-research-framework-for-developing-and-sharing-knowledge/]
Sushko I, Novotarskyi S, Körner R, Pandey AK, Rupp M, Teetz W, Brandmaier S, Abdelaziz A, Prokopenko VV, Tanchuk VY, Todeschini R, Varnek A, Marcou G, Ertl P, Potemkin V, Grishina M, Gasteiger J, Schwab C, Baskin II, Palyulin VA, Radchenko EV, Welsh WJ, Kholodovych V, Chekmarev D, Cherkasov A, Aires-De-Sousa J, Zhang Q-Y, Bender A, Nigsch F, Patiny L: Online chemical modeling environment (OCHEM): Web platform for data storage, model development and publishing of chemical information. J Comput Aided Mol Des. 2011, 25 (6): 533-554. 10.1007/s10822-011-9440-2.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kavlock R, Dix D: Computational toxicology as implemented by the U.S. EPA: Providing high throughput decision support tools for screening and assessing chemical exposure, hazard and risk. J Toxicol Environ Health B Crit Rev. 2010, 13 (2–4): 197-217.
Article
CAS
PubMed
Google Scholar
Hishigaki H, Kuhara S: hERGAPDbase: a database documenting hERG channel inhibitory potentials and APD-prolongation activities of chemical compounds. Database. 2011, 10.1093/database/bar017.. Published online 2011 May 17
Google Scholar
Du F, Yu H, Zou B, Babcock J, Long S, Li M: HERGCentral: A large database to store, retrieve, and analyze compound-human ether-à-go-go related gene channel interactions to facilitate cardiotoxicity assessment in drug development. Assay and Drug Development Technologies. 2011, 9 (6): 580-588. 10.1089/adt.2011.0425.
Article
CAS
PubMed
PubMed Central
Google Scholar
Polak S, Wisniowska B, Fijorek K, Glinka A, Polak M, Mendyk A: The open-access dataset for in silico cardiotoxicity prediction system. Bioinformation. 2011, 6 (6): 244-245. 10.6026/97320630006244.
Article
PubMed
PubMed Central
Google Scholar
Polak S, Wisniowska B, Glinka A, Fijorek K, Mendyk A: Slow delayed rectifying potassium current (IKs) – analysis of the in vitro inhibition data and predictive model development. J Appl Toxicol. 2012 Feb 14, doi: 10.1002/jat.2719. Epub ahead of print
Google Scholar
,: The Innovative Medicines Initiative. [http://www.imi.europa.eu/]
Ackerman MJ, Tester DJ, Jones GS, Will ML, Burrow CR, Curran ME: Ethnic differences in cardiac potassium channel variants: implications for genetic susceptibility to sudden cardiac death and genetic testing for congenital long QT syndrome. Mayo Clin Proc. 2003, 78 (12): 1479-87. 10.4065/78.12.1479.
Article
CAS
PubMed
Google Scholar
Arnestad M, Crotti L, Rognum TO, Insolia R, Pedrazzini M, Ferrandi C, Vege A, Wang DW, Rhodes TE, George AL, Schwartz PJ: Prevalence of long-QT syndrome gene variants in sudden infant death syndrome. Circulation. 2007, 115 (3): 361-367. 10.1161/CIRCULATIONAHA.106.658021.
Article
PubMed
Google Scholar
Burke A, Creighton W, Mont E, Li L, Hogan S, Kutys R, Fowler D, Virmani R: Role of SCN5A Y1102 polymorphism in sudden cardiac death in blacks. Circulation. 2005, 112 (6): 798-802. 10.1161/CIRCULATIONAHA.104.482760.
Article
CAS
PubMed
Google Scholar
Chen LY, Ballew JD, Herron KJ, Rodeheffer RJ, Olson TM: A common polymorphism in SCN5A is associated with lone atrial fibrillation. Clin Pharmacol Ther. 2007, 81 (1): 35-41. 10.1038/sj.clpt.6100016.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gouas L, Nicaud V, Berthet M, Forhan A, Tiret L, Balkau B, Guicheney P: D.E.S.I.R. Study Group. Association of KCNQ1, KCNE1, KCNH2 and SCN5A polymorphisms with QTc interval length in a healthy population. Eur J Hum Genet. 2005, 13 (11): 1213-1222. 10.1038/sj.ejhg.5201489.
Article
CAS
PubMed
Google Scholar
Marjamaa A, Newton-Cheh C, Porthan K, Reunanen A, Lahermo P, Väänänen H, Jula A, Karanko H, Swan H, Toivonen L, Nieminen MS, Viitasalo M, Peltonen L, Oikarinen L, Palotie A, Kontula K, Salomaa V: Common candidate gene variants are associated with QT interval duration in the general population. J Intern Med. 2009, 265 (4): 448-58. 10.1111/j.1365-2796.2008.02026.x.
Article
CAS
PubMed
PubMed Central
Google Scholar
The International Conference on Harmonisation: S7B guidline: Nonclinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation). 2005, Human Pharmaceuticals,http://www.fda.gov/RegulatoryInformation/Guidances/ucm129121.htm,
Google Scholar
Splawski I, Shen J, Timothy KW, Lehmann MH, Priori S, Robinson JL, Moss AJ, Schwartz PJ, Towbin JA, Vincent GM, Keating MT: Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation. 2000, 102 (10): 1178-1185. 10.1161/01.CIR.102.10.1178.
Article
CAS
PubMed
Google Scholar
Splawski I, Timothy KW, Tateyama M, Clancy CE, Malhotra A, Beggs AH, Cappuccio FP, Sagnella GA, Kass RS, Keating MT: Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia. Science. 2002, 297 (5585): 1333-1336. 10.1126/science.1073569.
Article
CAS
PubMed
Google Scholar
ten Tusscher KH, Noble D, Noble PJ, Panfilov AV: A model for human ventricular tissue. Am J Physiol Heart Circ Physiol. 2004, 286 (4): H1573-1589.
Article
CAS
PubMed
Google Scholar
Tester DJ, Ackerman MJ: Sudden infant death syndrome: how significant are the cardiac channelopathies?. Cardiovasc Res. 2005, 67 (3): 388-396. 10.1016/j.cardiores.2005.02.013.
Article
CAS
PubMed
Google Scholar
Vatta M, Dumaine R, Varghese G, Richard TA, Shimizu W, Aihara N, Nademanee K, Brugada R, Brugada J, Veerakul G, Li H, Bowles NE, Brugada P, Antzelevitch C, Towbin JA: Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome. Hum Mol Genet. 2002, 11 (3): 337-345. 10.1093/hmg/11.3.337.
Article
CAS
PubMed
Google Scholar
Yang P, Koopmann TT, Pfeufer A, Jalilzadeh S, Schulze-Bahr E, Kääb S, Wilde AA, Roden DM, Bezzina CR: Polymorphisms in the cardiac sodium channel promoter displaying variant in vitro expression activity. Eur J Hum Genet. 2008, 16 (3): 350-357. 10.1038/sj.ejhg.5201952.
Article
CAS
PubMed
Google Scholar
Splawski I, Timothy KW, Decher N, Kumar P, Sachse FB, Beggs AH, Sanguinetti MC, Keating MT: Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc Natl Acad Sci USA. 2005, 102 (23): 8089-8096. 10.1073/pnas.0502506102.
Article
CAS
PubMed
PubMed Central
Google Scholar
Splawski I, Timothy KW, Sharpe LM, Decher N, Kumar P, Bloise R, Napolitano C, Schwartz PJ, Joseph RM, Condouris K, Tager-Flusberg H, Priori SG, Sanguinetti MC, Keating MT: Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell. 2004, 119 (1): 19-31. 10.1016/j.cell.2004.09.011.
Article
CAS
PubMed
Google Scholar
Anson BD, Ackerman MJ, Tester DJ, Will ML, Delisle BP, Anderson CL, January CT: Molecular and functional characterization of common polymorphisms in HERG (KCNH2) potassium channels. Am J Physiol Heart Circ Physiol. 2004, 286 (6): H2434-2441. 10.1152/ajpheart.00891.2003.
Article
CAS
PubMed
Google Scholar
Bezzina CR, Verkerk AO, Busjahn A, Jeron A, Erdmann J, Koopmann TT, Bhuiyan ZA, Wilders R, Mannens MM, Tan HL, Luft FC, Schunkert H, Wilde AA: A common polymorphism in KCNH2 (HERG) hastens cardiac repolarization. Cardiovasc Res. 2003, 59 (1): 27-36. 10.1016/S0008-6363(03)00342-0.
Article
CAS
PubMed
Google Scholar
Cordeiro JM, Brugada R, Wu YS, Hong K, Dumaine R: Modulation of I(Kr) inactivation by mutation N588K in KCNH2: a link to arrhythmogenesis in short QT syndrome. Cardiovasc Res. 2005, 67 (3): 498-509. 10.1016/j.cardiores.2005.02.018.
Article
CAS
PubMed
Google Scholar
Koo SH, Ho WF, Lee EJ: Genetic polymorphisms in KCNQ1, HERG, KCNE1 and KCNE2 genes in the Chinese, Malay and Indian populations of Singapore. Br J Clin Pharmacol. 2006, 61 (3): 301-308. 10.1111/j.1365-2125.2005.02545.x.
Article
CAS
PubMed
Google Scholar
Laitinen P, Fodstad H, Piippo K, Swan H, Toivonen L, Viitasalo M, Kaprio J, Kontula K: Survey of the coding region of the HERG gene in long QT syndrome reveals six novel mutations and an amino acid polymorphism with possible phenotypic effects. Hum Mutat. 2000, 15 (6): 580-581.
Article
CAS
PubMed
Google Scholar
Larsen LA, Andersen PS, Kanters J, Svendsen IH, Jacobsen JR, Vuust J, Wettrell G, Tranebjaerg L, Bathen J, Christiansen M: Screening for mutations and polymorphisms in the genes KCNH2 and KCNE2 encoding the cardiac HERG/MiRP1 ion channel: implications for acquired and congenital long Q-T syndrome. Clin Chem. 2001, 47 (8): 1390-1395.
CAS
PubMed
Google Scholar
Lin Z, Li Z, Yafei L, Xiangyu M: MinK gene G112A polymorphisms and atrial fibrillation: a Meta-analysis. Journal of Medical Colleges of PLA. 2009, 24: 198-207. 10.1016/S1000-1948(09)60038-1.
Article
Google Scholar
Männikkö R, Overend G, Perrey C, Gavaghan CL, Valentin JP, Morten J, Armstrong M, Pollard CE: Pharmacological and electrophysiological characterization of nine, single nucleotide polymorphisms of the hERG-encoded potassium channel. Br J Pharmacol. 2010, 159 (1): 102-114. 10.1111/j.1476-5381.2009.00334.x.
Article
PubMed
Google Scholar
Paulussen AD, Gilissen RA, Armstrong M, Doevendans PA, Verhasselt P, Smeets HJ, Schulze-Bahr E, Haverkamp W, Breithardt G, Cohen N, Aerssens J: Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients. J Mol Med. 2004, 82 (3): 182-188. 10.1007/s00109-003-0522-z.
Article
CAS
PubMed
Google Scholar
Pietilä E, Fodstad H, Niskasaari E, Laitinen PPJ, Swan H, Savolainen M, Kesäniemi YA, Kontula K, Huikuri HV: Association between HERG K897T polymorphism and QT interval in middle-aged Finnish women. J Am Coll Cardiol. 2002, 40 (3): 511-514. 10.1016/S0735-1097(02)01979-4.
Article
PubMed
Google Scholar
Abbott GW, Sesti F, Splawski I, Buck ME, Lehmann MH, Timothy KW, Keating MT, Goldstein SA: MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell. 1999, 97 (2): 175-87. 10.1016/S0092-8674(00)80728-X.
Article
CAS
PubMed
Google Scholar
Bellocq C, van Ginneken AC, Bezzina CR, Alders M, Escande D, Mannens MM, Baró I, Wilde AA: Mutation in the KCNQ1 gene leading to the short QT-interval syndrome. Circulation. 2004, 109 (20): 2394-2397. 10.1161/01.CIR.0000130409.72142.FE.
Article
PubMed
Google Scholar
Ellinor PT, Moore RK, Patton KK, Ruskin JN, Pollak MR, Macrae CA: Mutations in the long QT gene, KCNQ1, are an uncommon cause of atrial fibrillation. Heart. 2004, 90 (12): 1487-1488. 10.1136/hrt.2003.027227.
Article
CAS
PubMed
PubMed Central
Google Scholar
Akyol M, Jalilzadeh S, Sinner MF, Perz S, Beckmann BM, Gieger C, Illig T, Wichmann HE, Meitinger T, Kääb S, Pfeufer A: The common non-synonymous variant G38S of the KCNE1-(minK)-gene is not associated to QT interval in Central European Caucasians: results from the KORA study. Eur Heart J. 2007, 28 (3): 305-309. 10.1093/eurheartj/ehl460.
Article
PubMed
Google Scholar
The ionic current inhibition database. [http://www.tox-database.net]
Mirams GR, Cui Y, Sher A, Fink M, Cooper J, Heath BM, McMahon NC, Gavaghan DJ, Noble D: Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk. Cardiovasc Res. 2011, 91 (1): 53-61. 10.1093/cvr/cvr044.
Article
CAS
PubMed
PubMed Central
Google Scholar
Towart R, Linders JTM, Hermans AN, Rohrbacher J, van der Linde HJ, Ercken M, Cik M, Roevens P, Teisman A, Gallacher DJ: Blockade of the IKs potassium channel: An overlooked cardiovascular liability in drug safety screening?. J Pharmacol Toxicol Meth. 2009, 60 (1): 1-10. 10.1016/j.vascn.2009.04.197.
Article
CAS
Google Scholar
Mirams GR, Davies MR, Cui Y, Kohl P, Noble D: Application of cardiac electrophysiology simulations to pro-arrhythmic safety testing. Br J Pharmacol. 2012, doi: 10.1111/j.1476-5381.2012.02020. May 9 x. [Epub ahead of print]
Google Scholar
Wisniowska B, Mendyk A, Fijorek K, Glinka A, Polak S: Predictive model for the L-type channel inhibition - multichannel block in QT prolongation risk assessment. J Appl Toxicol. Accepted for publication